Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02875925 · ClinicalTrials.gov registry record · NA

Outcomes Study of MTM in a Medicare ACO

A NA study of Pain and Hypoglycemia, sponsored by HealthEast Care System.

Completed
Registry status
NA
Development phase
77
Enrollment target
1
Study location

NCT02875925 is a NA study of Pain and Hypoglycemia that has completed, run by HealthEast Care System. The registered enrollment target is 77 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (75% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02875925, a NA study of Pain and Hypoglycemia, has completed, sponsored by HealthEast Care System.

COMPLETED
Registry status
NA
Development phase
77 participants
Enrollment target
1
Study location

Study Summary

This is a non-randomized, prospective, quasi-experimental study designed to assess the impact of pharmacist-provided medication management on total cost of care and clinical outcomes (ie, hospitalizations, emergency department visits) in a real-world clinical practice.

Conditions Studied

Interventions

  • OTHER MTM

Study Locations (1)

Minnesota

  • HealthEast Care System - Saint Paul

Trial Details

FieldValue
Enrollment Target 77 participants
Start Date 2015-12
Est. Completion 2017-12
Phase NA

Sponsor

HealthEast Care System

5 total trials

What the Registry Record Tells You About NCT02875925

The ClinicalTrials.gov registry entry for NCT02875925 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 77 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 304-participant average among 374 other Pain trials with a reported enrollment target (75% lower). The listed sponsor is HealthEast Care System, which has 5 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Pain appearing as the primary indexed condition, and to 1 intervention - of which MTM is the first listed.

NCT02875925 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT02875925 about?

NCT02875925 is a clinical study titled "Outcomes Study of MTM in a Medicare ACO". This is a non-randomized, prospective, quasi-experimental study designed to assess the impact of pharmacist-provided medication management on total cost of care and clinical outcomes (ie, hospitalizations, emergency department visits) in a real-world clinical practice.

What is the current status of trial NCT02875925?

This trial is currently completed. It is a NA study. The enrollment target is 77 participants. The study started on 2015-12. Estimated completion is 2017-12.

What conditions does trial NCT02875925 study?

This clinical trial studies the following conditions: Pain, Hypoglycemia.

What interventions are being tested in trial NCT02875925?

The interventions under investigation include: MTM (OTHER).

Who is sponsoring clinical trial NCT02875925?

This trial is sponsored by HealthEast Care System, which has 5 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02875925 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.